Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.
Orbital Therapeutics has raised $270.0M in total funding. The most recent round was Series A. The last funding was announced in April 2023.
Orbital Therapeutics's investors include Andreessen Horowitz, ARCH Venture Partners, Redmile Group, Casdin Capital, iGlobe Partners.
Orbital Therapeutics is headquartered in Cambridge, United States.
Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.
Orbital Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Orbital Therapeutics — Funding & Investors." VCBacked, April 26, 2023, https://www.vcbacked.co/company/orbital-therapeutics. Accessed September 8, 2026.
VCBacked. (2023). Orbital Therapeutics — Funding & Investors. Retrieved September 8, 2026, from https://www.vcbacked.co/company/orbital-therapeutics
{{cite web |title=Orbital Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/orbital-therapeutics |website=VCBacked |access-date=September 8, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated